Volume 270,
Number 2,
Issue of January 13, 1995 pp. 877-884
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Analysis
of the Binding Site on Intercellular Adhesion Molecule 3 for the
Leukocyte Integrin Lymphocyte Function-associated Antigen 1
(Received for publication, August 29, 1994; and in revised form, November 8, 1994)
Claire L.
Holness
,
Paul A.
Bates
,
Amanda
J.
Littler
,
Christopher D.
Buckley
,
Alison
McDowall
,
David
Bossy
,
Nancy
Hogg
,
David
L.
Simmons
Intercellular adhesion molecule 3 (ICAM-3, CD50) is a member of
the immunoglobulin superfamily and is a constitutively expressed ligand
for the leukocyte integrin LFA-1 (CD11a/CD18). ICAM-3 is expressed at
high levels by all resting leukocyte populations and antigen presenting
cells and is a major ligand for LFA-1 in the resting immune system.
ICAM-3 is a signal transducer and may play a key role in initiating
immune responses. Mutant ICAM-3 Fc-chimeric proteins were
quantitatively analyzed for their ability to bind COS cells expressing
human LFA-1. The LFA-1-binding site on ICAM-3 is located in the
N-terminal 2 Ig domains. Domains 3-5 do not significantly
contribute to adhesion. The binding site has been further resolved by
rational targeting of 14 point mutations throughout domains 1 and 2,
coupled with modeling studies. Within domain 1 a cluster of residues
(Glu
, Leu
, Ser
, and
Gln
), that are predicted to lie on the CC`FG face of the
Ig fold, play a dominant role in LFA-1 binding.